US2011229871A1PendingUtilityA1
Nucleoside-containing compositions and methods for treating red blood cells
Est. expiryFeb 16, 2030(~3.6 yrs left)· nominal 20-yr term from priority
Inventors:Daniel G. Ericson
A61K 31/19A61K 31/7068A61K 33/42A61K 31/7052A61K 31/7004A61K 35/18A01N 1/126
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Blood storage and/or rejuvenating compositions that include D-ribose and a nucleoside other than inosine (e.g., guanosine) are disclosed herein. Such compositions can be useful in methods for treating (e.g., storing and/or rejuvenating) red blood cells.
Claims
exact text as granted — not AI-modified1 . A blood storage and/or rejuvenating composition comprising a nucleoside and D-ribose, with the proviso that the nucleoside is not inosine.
2 . The composition of claim 1 wherein the nucleoside is selected from the group consisting of adenosine, deoxyadenosine, guanosine, deoxyguanosine, 5′-methyluridine, thymidine, uridine, deoxyuridine, cytidine, and deoxycytidine.
3 . The composition of claim 1 wherein the nucleoside is guanosine.
4 . The composition of claim 1 further comprising sodium pyruvate.
5 . The composition of claim 1 further comprising an inorganic phosphate.
6 . The composition of claim 1 wherein the composition is an aqueous solution.
7 . A blood storage and/or rejuvenating composition comprising 75 to 1500 mM guanosine.
8 . The composition of claim 7 further comprising D-ribose.
9 . The composition of claim 8 wherein the concentration of the D-ribose is 75 to 1500 mM.
10 . The composition of claim 7 further comprising sodium pyruvate.
11 . The composition of claim 10 wherein the concentration of the sodium pyruvate is 75 to 1500 mM.
12 . The composition of claim 7 further comprising an inorganic phosphate.
13 . The composition of claim 12 wherein the concentration of the inorganic phosphate is 75 to 1500 mM.
14 . The composition of claim 7 further comprising inosine.
15 . The composition of claim 7 further comprising L-arginine.
16 . The composition of claim 15 wherein the concentration of the L-arginine is 75 to 1500 mM.
17 . A blood storage and/or rejuvenating composition comprising:
225 mM guanosine; 300 mM D-ribose; 300 mM sodium pyruvate; and 300 mM inorganic phosphate.
18 . A method of storing blood, the method comprising contacting red blood cells with a blood storage and/or rejuvenating composition according to claim 1 .
19 . The method of claim 18 wherein the red blood cells are packed red blood cells or in whole blood.
20 . A method of rejuvenating blood, the method comprising contacting red blood cells with a blood storage and/or rejuvenating composition according to claim 1 .
21 . The method of claim 20 wherein the red blood cells are packed red blood cells or in whole blood.
22 . A method of rejuvenating blood, the method comprising:
providing red blood cells having a 2,3-diphosphoglycerate value lower than the value for freshly drawn blood; and mixing the red blood cells with a blood storage and/or rejuvenating composition under conditions effective to increase the 2,3-diphosphoglycerate value, wherein the blood storage and/or rejuvenating composition comprises guanosine.
23 . The method of claim 22 wherein conditions effective comprise incubating the cells in the blood storage and/or rejuvenating composition at a temperature of 4° C. to 37° C.
24 . The method of claim 23 wherein the temperature is room temperature.
25 . The method of claim 22 wherein conditions effective comprise incubating the cells in the blood storage and/or rejuvenating composition for a time of at least 10 minutes.
26 . The method of claim 25 wherein the time is 10 minutes to 48 hours.
27 . The method of claim 26 wherein the time is 10 minutes to 4 hours.
28 . The method of claim 27 wherein the time is 30 minutes to 2 hours.
29 . The method of claim 22 wherein the blood storage and/or rejuvenating composition further comprises D-ribose.
30 . The method of claim 22 wherein the red blood cells are packed red blood cells or in whole blood.
31 . A method of rejuvenating blood, the method comprising:
providing red blood cells having an adenosine triphosphate value lower than the value for freshly drawn blood; and mixing the red blood cells with a blood storage and/or rejuvenating composition under conditions effective to increase the adenosine triphosphate value, wherein the blood storage and/or rejuvenating composition comprises guanosine.Join the waitlist — get patent alerts
Track US2011229871A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.